Loading…

Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Transplant-Ineligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Clinical Assessment of Key Subgroups of the Phase 3 Maia Study

Saved in:
Bibliographic Details
Main Authors: Moreau, Philippe, Facon, Thierry, Usmani, Saad, Bahlis, Nizar Jacques, Raje, Noopur, Plesner, Torben, Orlowski, Robert Z., Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P., Weisel, Katja, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Pei, Huiling, Krevvata, Maria, Carson, Robin, Borgsten, Fredrik, Kumar, Shaji K
Format: Conference Proceeding
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-163494